Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 2
2001 1
2004 2
2006 3
2007 2
2008 1
2009 1
2010 1
2011 2
2012 3
2013 2
2014 2
2015 3
2016 3
2017 1
2020 1
2021 5
2022 4
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Risk assessment and antibody responses to SARS-CoV-2 in healthcare workers.
Bansal A, Trieu MC, Mohn KGI, Madsen A, Olofsson JS, Sandnes HH, Sævik M, Søyland H, Hansen L, Onyango TB, Tøndel C, Brokstad KA; Bergen COVID-19 research group; Syre H, Riis ÅG, Langeland N, Cox RJ. Bansal A, et al. Front Public Health. 2023 Jul 21;11:1164326. doi: 10.3389/fpubh.2023.1164326. eCollection 2023. Front Public Health. 2023. PMID: 37546332 Free PMC article.
Seroconversion in household members of COVID-19 outpatients.
Cox RJ, Brokstad KA, Krammer F, Langeland N; Bergen COVID-19 Research Group. Cox RJ, et al. Lancet Infect Dis. 2021 Feb;21(2):168. doi: 10.1016/S1473-3099(20)30466-7. Epub 2020 Jun 15. Lancet Infect Dis. 2021. PMID: 32553187 Free PMC article. No abstract available.
SARS-CoV-2 specific immune responses in overweight and obese COVID-19 patients.
Onyango TB, Zhou F, Bredholt G, Brokstad KA, Lartey S, Mohn KG, Özgümüs T, Kittang BR, Linchausen DW, Shafiani S, Elyanow R, Blomberg B, Langeland N, Cox RJ; Bergen COVID-19 Research Group. Onyango TB, et al. Among authors: bredholt g. Front Immunol. 2023 Nov 2;14:1287388. doi: 10.3389/fimmu.2023.1287388. eCollection 2023. Front Immunol. 2023. PMID: 38022529 Free PMC article.
Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients.
Mohn KG, Bredholt G, Zhou F, Madsen A, Onyango TB, Fjelltveit EB, Jalloh SL, Brokstad KA, Cantoni D, Mayora-Neto M, Temperton N, Langeland N, Cox RJ; Bergen COVID-19 research group. Mohn KG, et al. Among authors: bredholt g. PLoS One. 2022 Feb 22;17(2):e0261979. doi: 10.1371/journal.pone.0261979. eCollection 2022. PLoS One. 2022. PMID: 35192617 Free PMC article. Clinical Trial.
Long COVID in a prospective cohort of home-isolated patients.
Blomberg B, Mohn KG, Brokstad KA, Zhou F, Linchausen DW, Hansen BA, Lartey S, Onyango TB, Kuwelker K, Sævik M, Bartsch H, Tøndel C, Kittang BR; Bergen COVID-19 Research Group; Cox RJ, Langeland N. Blomberg B, et al. Nat Med. 2021 Sep;27(9):1607-1613. doi: 10.1038/s41591-021-01433-3. Epub 2021 Jun 23. Nat Med. 2021. PMID: 34163090 Free PMC article.
Durable immune responses after BNT162b2 vaccination in home-dwelling old adults.
Hansen L, Brokstad KA, Bansal A, Zhou F, Bredholt G, Onyango TB, Sandnes HH, Elyanow R, Madsen A, Trieu MC, Sævik M, Søyland H, Olofsson JS, Vahokoski J, Ertesvåg NU, Fjelltveit EB, Shafiani S, Tøndel C, Chapman H, Kaplan I, Mohn KGI, Langeland N, Cox RJ. Hansen L, et al. Among authors: bredholt g. Vaccine X. 2023 Apr;13:100262. doi: 10.1016/j.jvacx.2023.100262. Epub 2023 Jan 10. Vaccine X. 2023. PMID: 36643855 Free PMC article.
SARS-CoV-2 infection induces long-lived B and T-cell responses up to 15 months post-infection, irrespective of disease severity.
Mohn KG, Bredholt G, Onyango TB, Brokstad KA, Zhou F, Holter JC, Tonby K, Dyrhol-Riise AM, Cox RJ; Bergen COVID-19 Research Group; Norwegian SARS-CoV-2 Study Group. Mohn KG, et al. Among authors: bredholt g. J Infect. 2023 Oct;87(4):346-349. doi: 10.1016/j.jinf.2023.05.023. Epub 2023 Jun 8. J Infect. 2023. PMID: 37295510 Free PMC article.
Harmonization and qualification of an IFN-γ Enzyme-Linked ImmunoSpot assay (ELISPOT) to measure influenza-specific cell-mediated immunity within the FLUCOP consortium.
Waerlop G, Leroux-Roels G, Lambe T, Bellamy D, Medaglini D, Pettini E, Cox RJ, Trieu MC, Davies R, Bredholt G, Montomoli E, Gianchecchi E, Clement F. Waerlop G, et al. Among authors: bredholt g. Front Immunol. 2022 Sep 8;13:984642. doi: 10.3389/fimmu.2022.984642. eCollection 2022. Front Immunol. 2022. PMID: 36159843 Free PMC article.
A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern.
Ertesvåg NU, Xiao J, Zhou F, Ljostveit S, Sandnes H, Lartey S, Sævik M, Hansen L, Madsen A, Mohn KGI, Fjelltveit E, Olofsson JS, Tan TK, Rijal P, Schimanski L, Øyen S, Brokstad KA, Dunachie S, Jämsén A, James WS, Harding AC, Harvala H, Nguyen D, Roberts D; PHE Virology group; Zambon M; Oxford collaborative group; Townsend A; Bergen COVID-19 Research Group; Langeland N, Cox RJ. Ertesvåg NU, et al. Commun Med (Lond). 2022 Apr 5;2:36. doi: 10.1038/s43856-022-00091-x. eCollection 2022. Commun Med (Lond). 2022. PMID: 35603265 Free PMC article.
42 results